Goldman Sachs’s Delcath Systems DCTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.15M Sell
250,312
-38,819
-13% -$429K ﹤0.01% 4299
2026
Q1
$2.68M Sell
289,131
-298,547
-51% -$2.89M ﹤0.01% 4267
2025
Q4
$5.94M Buy
587,678
+315,583
+116% +$3.14M ﹤0.01% 3592
2025
Q3
$2.93M Buy
272,095
+118,541
+77% +$1.32M ﹤0.01% 4136
2025
Q2
$2.09M Buy
153,554
+30,067
+24% +$419K ﹤0.01% 4147
2025
Q1
$1.57M Buy
123,487
+45,695
+59% +$649K ﹤0.01% 4349
2024
Q4
$937K Buy
77,792
+57,734
+288% +$609K ﹤0.01% 4867
2024
Q3
$181K Sell
20,058
-19,004
-49% -$165K ﹤0.01% 5487
2024
Q2
$327K Buy
+39,062
New +$248K ﹤0.01% 5057
2021
Q2
Sell
-10,097
Closed -$125K 6257
2021
Q1
$125K Buy
+10,097
New +$186K ﹤0.01% 5778

Other funds holding DCTH

Goldman Sachs's DCTH Position: Q2 2026 in Review

Goldman Sachs reduced its Delcath Systems (DCTH) stake by 13% in Q2 2026, selling an estimated $429K and leaving 250,312 shares worth $3.15M. The position accounts for ﹤0.01% of the portfolio, ranked #4299.

Goldman Sachs first reported a position in DCTH in Q1 2021 and has held it in 10 quarters since. The position peaked at $5.94M in Q4 2025. 120 funds tracked by Wall St. Rank hold DCTH as of Q2 2026.

  • Goldman Sachs held 250,312 shares of Delcath Systems worth $3.15M as of Q2 2026.
  • Goldman Sachs sold 38,819 Delcath Systems shares in Q2 2026, an estimated $429K.
  • Delcath Systems made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4299 holding.
  • Goldman Sachs first reported a position in Delcath Systems in Q1 2021 and has held it in 10 quarters since.
  • Goldman Sachs's Delcath Systems position peaked at $5.94M in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Delcath Systems as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.